m (Add company logo.) |
(Added off-label marketing of Zyprexa scandal.) |
||
| Line 7: | Line 7: | ||
| key_people = David A. Ricks <small>([[Chairperson]], [[President (corporate title)|President]], & [[Chief Executive Officer|CEO]])</small><br /> | | key_people = David A. Ricks <small>([[Chairperson]], [[President (corporate title)|President]], & [[Chief Executive Officer|CEO]])</small><br /> | ||
Anat Ashkenazi <small>(Vice president & [[CFO]])<ref>{{News citation|title-url=https://www.marketwatch.com/story/lilly-promotes-anat-ashkenazi-to-cfo-says-previous-cfo-had-inappropriate-communication-with-employees-2021-02-09|date=9 February 2021|access-date=20 February 2021|author=Jaimy Lee|newspaper=Market Watch|title=Lilly promotes Anat Ashkenazi to CFO, says previous CFO had 'inappropriate' communication with employees|archive-date=9 February 2021|archive-url=https://web.archive.org/web/20210209212406/https://www.marketwatch.com/story/lilly-promotes-anat-ashkenazi-to-cfo-says-previous-cfo-had-inappropriate-communication-with-employees-2021-02-09|url-status=live}}</ref></small> | Anat Ashkenazi <small>(Vice president & [[CFO]])<ref>{{News citation|title-url=https://www.marketwatch.com/story/lilly-promotes-anat-ashkenazi-to-cfo-says-previous-cfo-had-inappropriate-communication-with-employees-2021-02-09|date=9 February 2021|access-date=20 February 2021|author=Jaimy Lee|newspaper=Market Watch|title=Lilly promotes Anat Ashkenazi to CFO, says previous CFO had 'inappropriate' communication with employees|archive-date=9 February 2021|archive-url=https://web.archive.org/web/20210209212406/https://www.marketwatch.com/story/lilly-promotes-anat-ashkenazi-to-cfo-says-previous-cfo-had-inappropriate-communication-with-employees-2021-02-09|url-status=live}}</ref></small> | ||
| industry = | | industry = Pharmacy | ||
| products = [[Pharmaceutical drugs]] | | products = [[Pharmaceutical drugs]] | ||
| revenue = +US$22.319 billion {{small|(2019)<ref name="Eli 19">{{Citation|title-url=https://investor.lilly.com/static-files/34d71960-241f-4160-bd20-86fb85df4def|title=Eli Lilly and Company 2019 Annual Report | newspaper=Eli Lilly | date=19 February 2020 | access-date=21 December 2020 | archive-date=1 August 2022 | archive-url=https://web.archive.org/web/20220801022704/https://investor.lilly.com/static-files/34d71960-241f-4160-bd20-86fb85df4def}}</ref>}} | | revenue = +US$22.319 billion {{small|(2019)<ref name="Eli 19">{{Citation|title-url=https://investor.lilly.com/static-files/34d71960-241f-4160-bd20-86fb85df4def|title=Eli Lilly and Company 2019 Annual Report | newspaper=Eli Lilly | date=19 February 2020 | access-date=21 December 2020 | archive-date=1 August 2022 | archive-url=https://web.archive.org/web/20220801022704/https://investor.lilly.com/static-files/34d71960-241f-4160-bd20-86fb85df4def}}</ref>}} | ||
| Line 19: | Line 19: | ||
[[Eli Lilly and Company]], often shortened to '''Eli Lilly''', is a [[United States of America|U.S]]-based pharmaceutical corporation. | [[Eli Lilly and Company]], often shortened to '''Eli Lilly''', is a [[United States of America|U.S]]-based pharmaceutical corporation. | ||
== | ==Controversies== | ||
On July 20, 2019; Eli Lilly was found to have bribed the Jury and victims of mass shootings 20 million dollars, in multiple lawsuits against Eli Lily for murder from Prozac, to hide evidence of Prozac increasing the rate of mass | ===Prozac Jury corruption=== | ||
On July 20, 2019; Eli Lilly was found to have bribed the Jury and victims of mass shootings 20 million dollars, in multiple lawsuits against Eli Lily for murder from Prozac, to hide evidence of Prozac increasing the rate of mass shootings.<ref>{{News citation|title=Prozac maker paid millions to secure favorable verdict in mass shooting lawsuit, victims say|url=https://www.azcentral.com/story/news/nation/2019/09/12/prozac-makers-secret-payment-mass-shooting-lawsuit-revealed/2302888001/|date=2019-09-12T12:33Z−07:00|author=Andrew Wolfson|publisher=ALLIANCE FOR HUMAN RESEARCH PROTECTION}}</ref> | |||
===Off-label marketing of Zyprexa=== | |||
In 2007, Eli Lilly and Company had paid $1.415 billion to resolve allegations regarding promotion of off-label usage of Zyprexa.<ref name=:0>{{News citation|title=Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa|url=https://www.justice.gov/opa/pr/eli-lilly-and-company-agrees-pay-1415-billion-resolve-allegations-label-promotion-zyprexa|date=2009-01-15|newspaper=Office of Public Affairs}}</ref> Eli Lilly also paid up to $800 million in a civil settlement with the federal government and the states.<ref name=:0 /> | |||
==References== | ==References== | ||
<references /> | <references /> | ||
Revision as of 12:02, 12 September 2022
Eli Lilly and Company | |
|---|---|
 | |
| Founder | Eli Lilly |
| Industry | Pharmacy |
| Key people | David A. Ricks (Chairperson, President, & CEO) Anat Ashkenazi (Vice president & CFO)[1] |
| Ownership | Lilly Endowment, 11.6%[2] |
| Revenue | +US$22.319 billion (2019)[3] |
| Net income | +US$8.318 (2019)[3] |
| Total assets | -US$39.286 (2019)[3] |
| Website | |
| www.lilly.com | |
Eli Lilly and Company, often shortened to Eli Lilly, is a U.S-based pharmaceutical corporation.
Controversies
Prozac Jury corruption
On July 20, 2019; Eli Lilly was found to have bribed the Jury and victims of mass shootings 20 million dollars, in multiple lawsuits against Eli Lily for murder from Prozac, to hide evidence of Prozac increasing the rate of mass shootings.[4]
Off-label marketing of Zyprexa
In 2007, Eli Lilly and Company had paid $1.415 billion to resolve allegations regarding promotion of off-label usage of Zyprexa.[5] Eli Lilly also paid up to $800 million in a civil settlement with the federal government and the states.[5]
References
- ↑ Jaimy Lee (9 February 2021). Lilly promotes Anat Ashkenazi to CFO, says previous CFO had 'inappropriate' communication with employees Market Watch. Archived from the original on 9 February 2021.
- ↑ Document.
- ↑ 3.0 3.1 3.2 Eli Lilly and Company 2019 Annual Report (19 February 2020).
- ↑ Andrew Wolfson (2019-09-12T12:33Z−07:00). "Prozac maker paid millions to secure favorable verdict in mass shooting lawsuit, victims say"
- ↑ 5.0 5.1 "Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegationsof Off-label Promotion of Zyprexa" (2009-01-15). Office of Public Affairs.